IABP-SHOCK II Trial - Kardio.hr

More documents

Recommendations

Info

Background IABP Use (%) 90 80 70 60 50 40 30 20 10 0 11 ALKK IABP-Use in Cardiogenic Shock 22 GUSTO I 22 GUSTO III Euro Heart Survey 25 25 Worcester-Registry 31 NRMI-2 39 NRMI 2-4 51 SHOCK-Registry 86 SHOCK-Trial Thiele et al. Eur Heart J 2010,31:1828-1835
Methods Study Sites and Organisation DSMB: Kurt Huber Ferenc Follath Bernhard Maisch Johannes Haerting Steering committee: Holger Thiele Karl Werdan Uwe Zeymer Gerhard Schuler Support + Patronage:
Page 1 and 2: Randomized comparison of intraaorti
Page 3 and 4: Background IABP in Cardiogenic Shoc
Page 5: Background Mortality IABP vs no IAB
Page 9 and 10: Methods Statistical Methodology Sam
Page 11 and 12: Results Age (years); median (IQR) M
Page 13 and 14: Results Simplified Acute Physiology
Page 15 and 16: Results Serum Lactate (mmol/l) 9 8
Page 17 and 18: Results Primary Study Endpoint (30-
Page 19 and 20: Results Safety IABP (n=300) Control
Page 21 and 22: Summary + Conclusions • IABP supp
Page 23: www.nejm.org

IABP-SHOCK II Trial - Kardio.hr

Create successful ePaper yourself

Delete template?

Save as template?